Top Tweets for #WaveLifeSciences
$TRDA — Valye Company Analysis #biotech #SareptaTherapeutics #IonisPharmaceuticals #WaveLifeSciences
Entrada Therapeutics is advancing several clinical-stage programs for rare neuromuscular and ocular diseases using its EEV intracellular delivery platform. With ongoing trials targeting Duchenne muscular dystrophy (DMD) mutations and a coll
Key points:
• Entrada’s EEV platform targets intracellular delivery, aiming to overcome key bottlenecks in genetic medicine efficacy [S1].
• Lead programs include multiple exon-skipping therapies for DMD and early-stage candidates for inherited retinal diseases [S1] [S2].
• The company advanced to the highest planned dose in its DMD study, marking a clinical milestone [N4].
• No approved products or commercial revenue; Entrada posted a Q3 2026 net loss of $39.7 million with $112.2 million in cash and equivalents [S2] [N1].
• There is substantial doubt about Entrada’s ability to continue as a going concern beyond Q4 2027 without additional financing [S2].
$DYN — Valye Company Analysis #biotech #SareptaTherapeutics #WaveLifeSciences #SolidBiosciences
Dyne Therapeutics advances late-stage programs in Duchenne and myotonic dystrophy, reporting a $193.6M net loss in Q3 2026 but maintaining $913.2M in cash—extending runway into Q2 2028. Orphan drug designation and early functional data in D
Key points:
• Dyne’s muscle-disease pipeline features two pivotal trials—DMD (Zeleciment Rostudirsen) and DM1 (Z-basivarsen)—with major 2027 milestones ahead. [N1]
• The company reported cash and cash equivalents of $913.2 for the period. [S2] [N2]
• Orphan drug designation in Japan and one-year functional improvement data for the DM1 program may support regulatory and commercial positioning. [N1]
• FDA clearance for a Phase 1 FSHD program (DYNE-302) expands the rare disease pipeline. [N8]
• Risks center on clinical trial outcomes, regulatory approvals, sustained R&D burn, and sector-wide competitive pressures.
「2395 新日本科学」
同社の重要投資先であるウェーブ・ライフ・サイエンスが材料発表を受け、8日のナスダック市場で2.5倍近く上昇しております。6月に開催された創薬力向上のための官民協議・・・
続きはコチラ
https://t.co/t1cvjwooli
#新日本科学 #ウェーブ・ライフ・サイエンス #WaveLifeSciences
🚨 Weekly US #StockMarket Recap Oct 14-18📈
#SP500 up 0.6%!
This week's top movers:
⬆️ $WVE #WaveLifeSciences +76% 🚀
⬆️ $PKDC #PKDataCorporation +38%
https://t.co/z9EYM9Ae39
⬆️ $COIN #Coinbase +22%
⬇️ $LCID #LucidMotors -22%
⬇️ $MGPI #MGPIngredients -22%
⬇️ $KLAC #KLA -16%
𝙂𝙤𝙤𝙙 𝙣𝙚𝙬𝙨! Wave Life Sciences has announced the positive results from SELECT-HD. Read their letter to the HD community below. #HuntingtonsDisease #HDCommunity #Huntington #HuntingtonResearch #WaveLifeSciences #HDNA
https://t.co/3WVFphXTeA
More good news in HD clinical trial land - this time from #WaveLifeSciences
Read Wave's press release: https://t.co/hC6Yi7Ac1D
and community letter: https://t.co/pYm8m6fmyV
#research #cures #huntingtonsdisease #cureHD
@HDBuzzFeed @HDSA @HDYOFeed @HuntingtonSG
Ringing the closing bell as NASDAQ. #wavelifesciences
#NVIDIA Down Before Earnings; #Textron, Wave Life Sciences and #Shopify Downgraded $NVDA, $TXT, $WVE, $SHOP, #WaveLifeSciences
https://t.co/8jzkafNWHZ
$WVE's price moved below its 50-day Moving Average on September 26, 2019. View odds for this and other indicators: https://t.co/LHT2mu0DoP #WaveLifeSciences #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today
Today’s #patientdriven advocacy summit is another amazing Boston @MassBio event where people have time to listen and learn from each other. TY Mass Bio, Kinser @HDSA and all of the great speaker and panelists! #wavelifesciences
Highlight of tonight’s @theangelfundals gala was the huge $ donated to UMass Medical School & Dr. Bob Brown’s research to find a cure for ALS #wavelifesciences
#EHDN2018 opening session underway and @DrEdWild talking about silver linings in #Huntingtondisease research happening now #wavelifesciences
#WaveLifeSciences presenta il #trial con gli #oligoantisenso stereopuri per #skipping esone 51 e futuri programmi per esone 53 #PPMDConference
“What we could see right away is that our exon skipping oligo gets where it needs to go” in #wavelifesciences investigational preclinical studies #PPMDConference
Ready to present at #PPMDConference is #wavelifesciences CEO Paul Bolno sharing updates on Wave’s exon skipping programS!
Day 2 of #PPMDConference starts with Ryan talking about patient focused drug development and the voice that matters - the voice of patients #wavelifesciences we agree!
TY to Amber Sapp who gave one of the most powerful DMD presentations ever - keeping it personal and real about clinical trials #PPMDConference #wavelifesciences
Arriving at Boston Common for the #MDAMusclewalk today! Raising awareness of #Duchenne muscular dystrophy and #ALS. Come join #wavelifesciences!
Last Seen Hashtags on Sotwe
diyarbakirescort
Seen from Turkey
맨발풋잡
Seen from Korea
PublicFISTING
Seen from Kenya
ล่อชายแท้
Seen from Thailand
shemale #exhibitionist
Seen from Switzerland
urfabayan
Seen from Turkey
maryjanebijoux
Seen from United States
導火線に火を灯して_info
Seen from United States
brosis
Seen from United States
monkeyappwin
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers